Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Insurance Type and Solid Organ Transplant Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplant Outcomes.

DuBay DA, MacLennan PA, Reed RD, Shelton BA, Redden DT, Fouad M, Martin MY, Gray SH, White JA, Eckhoff DE, Locke JE.

J Am Coll Surg. 2016 Jul 22. pii: S1072-7515(16)30683-4. doi: 10.1016/j.jamcollsurg.2016.07.004. [Epub ahead of print]

PMID:
27457252
2.

Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients.

Shelton BA, Mehta S, Sawinski D, Reed RD, MacLennan PA, Gustafson S, Segev DL, Locke JE.

Am J Transplant. 2016 Jun 15. doi: 10.1111/ajt.13922. [Epub ahead of print]

PMID:
27305590
3.

Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis.

Donnelly JP, Locke JE, MacLennan PA, McGwin G Jr, Mannon RB, Safford MM, Baddley JW, Muntner P, Wang HE.

Clin Infect Dis. 2016 Jul 15;63(2):186-94. doi: 10.1093/cid/ciw295. Epub 2016 May 23.

PMID:
27217215
4.

Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients.

Locke JE, Shelton BA, Reed RD, MacLennan PA, Mehta S, Sawinski D, Segev DL.

Am J Transplant. 2016 Aug;16(8):2377-83. doi: 10.1111/ajt.13847. Epub 2016 Jun 15.

PMID:
27140837
5.

Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus.

Kucirka LM, Durand CM, Bae S, Avery RK, Locke JE, Orandi BJ, McAdams-DeMarco M, Grams ME, Segev DL.

Am J Transplant. 2016 Aug;16(8):2368-76. doi: 10.1111/ajt.13840. Epub 2016 May 25.

PMID:
27111897
6.

Anti-Blood Group Antibodies in Intravenous Immunoglobulin May Complicate Interpretation of Antibody Titers in ABO-Incompatible Transplantation.

Staley EM, Carruba SS, Manning M, Pham HP, Williams LA 3rd, Marques MB, Locke JE, Lorenz RG.

Am J Transplant. 2016 Aug;16(8):2483-6. doi: 10.1111/ajt.13760. Epub 2016 Mar 17.

PMID:
26913485
7.

Hospital-onset Clostridium difficile infection among solid organ transplant recipients.

Donnelly JP, Wang HE, Locke JE, Mannon RB, Safford MM, Baddley JW.

Am J Transplant. 2015 Nov;15(11):2970-7. doi: 10.1111/ajt.13491.

PMID:
26484839
8.

A systematic review of the use of expandable cages in the cervical spine.

Elder BD, Lo SF, Kosztowski TA, Goodwin CR, Lina IA, Locke JE, Witham TF.

Neurosurg Rev. 2016 Jan;39(1):1-11; discussion 11. doi: 10.1007/s10143-015-0649-8. Epub 2015 Jul 28.

PMID:
26212700
9.

Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.

Locke JE, Durand C, Reed RD, MacLennan PA, Mehta S, Massie A, Nellore A, DuBay D, Segev DL.

Transplantation. 2016 Jan;100(1):141-6. doi: 10.1097/TP.0000000000000829.

PMID:
26177090
10.

The biomechanics of pedicle screw augmentation with cement.

Elder BD, Lo SF, Holmes C, Goodwin CR, Kosztowski TA, Lina IA, Locke JE, Witham TF.

Spine J. 2015 Jun 1;15(6):1432-45. doi: 10.1016/j.spinee.2015.03.016. Epub 2015 Mar 20. Review.

PMID:
25797809
11.

A systematic assessment of the use of platelet-rich plasma in spinal fusion.

Elder BD, Holmes C, Goodwin CR, Lo SF, Puvanesarajah V, Kosztowski TA, Locke JE, Witham TF.

Ann Biomed Eng. 2015 May;43(5):1057-70. doi: 10.1007/s10439-015-1300-0. Epub 2015 Mar 21. Review.

PMID:
25794962
12.

A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.

Locke JE, Mehta S, Reed RD, MacLennan P, Massie A, Nellore A, Durand C, Segev DL.

J Am Soc Nephrol. 2015 Sep;26(9):2222-9. doi: 10.1681/ASN.2014070726. Epub 2015 Mar 19.

PMID:
25791727
13.

Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients.

Locke JE, Reed RD, Mehta SG, Durand C, Mannon RB, MacLennan P, Shelton B, Martin MY, Qu H, Shewchuk R, Segev DL.

Am J Transplant. 2015 Aug;15(8):2096-104. doi: 10.1111/ajt.13220. Epub 2015 Mar 13.

14.

Identification of strategies to facilitate organ donation among African Americans using the nominal group technique.

Locke JE, Qu H, Shewchuk R, Mannon RB, Gaston R, Segev DL, Mannon EC, Martin MY.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):286-93. doi: 10.2215/CJN.05770614. Epub 2015 Jan 29.

15.

The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costs.

DuBay DA, MacLennan PA, Reed RD, Fouad M, Martin M, Meeks CB, Taylor G, Kilgore ML, Tankersley M, Gray SH, White JA, Eckhoff DE, Locke JE.

Am J Transplant. 2015 Feb;15(2):541-6. doi: 10.1111/ajt.12981.

16.

Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation.

Orandi BJ, Zachary AA, Dagher NN, Bagnasco SM, Garonzik-Wang JM, Van Arendonk KJ, Gupta N, Lonze BE, Alachkar N, Kraus ES, Desai NM, Locke JE, Racusen LC, Segev DL, Montgomery RA.

Transplantation. 2014 Oct 27;98(8):857-63. doi: 10.1097/TP.0000000000000298.

PMID:
25121475
17.

To whom goes the kidney?

Locke JE.

Liver Transpl. 2014 Sep;20(9):1017-8. doi: 10.1002/lt.23953. No abstract available.

18.

The authors' reply.

Locke JE, Segev DL.

Transplantation. 2014 Jun 27;97(12):e70-1. doi: 10.1097/TP.0000000000000193. No abstract available.

PMID:
24933253
19.

Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteria.

DuBay DA, Redden DT, Bryant MK, Dorn DP, Fouad MN, Gray SH, White JA, Locke JE, Meeks CB, Taylor GC, Kilgore ML, Eckhoff DE.

Transplantation. 2014 May 27;97(10):1043-8. doi: 10.1097/01.TP.0000441093.32217.cb.

20.

Is there a role for detection of complement-binding antibodies in kidney transplantation?

Locke JE, Segev DL.

Am J Kidney Dis. 2014 Apr;63(4):558-60. doi: 10.1053/j.ajkd.2014.01.007. Epub 2014 Jan 28. No abstract available.

PMID:
24480655
Items per page

Supplemental Content

Loading ...
Write to the Help Desk